Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1971 Oct 16;4(5780):128–129.

Anticoagulant interactions.

PMCID: PMC1799014  PMID: 5113012

Full text

PDF
128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggeler P. M., O'Reilly R. A., Leong L., Kowitz P. E. Potentiation of anticoagulant effect of warfarin by phenylbutazone. N Engl J Med. 1967 Mar 2;276(9):496–501. doi: 10.1056/NEJM196703022760904. [DOI] [PubMed] [Google Scholar]
  2. Antlitz A. M., Mead J. A., Jr, Tolentino M. A. Potentiation of oral anticoagulant therapy by acetaminophen. Curr Ther Res Clin Exp. 1968 Oct;10(10):501–507. [PubMed] [Google Scholar]
  3. Breckenridge A., Orme M. L., Thorgeirsson S., Davies D. S., Brooks R. V. Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine). Clin Sci. 1971 Apr;40(4):351–364. doi: 10.1042/cs0400351. [DOI] [PubMed] [Google Scholar]
  4. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  5. Coon W. W., Willis P. W., 3rd Some aspects of the pharmacology of oral anticoagulants. Clin Pharmacol Ther. 1970 May-Jun;11(3):312–336. doi: 10.1002/cpt1970113312. [DOI] [PubMed] [Google Scholar]
  6. Cucinell S. A., Odessky L., Weiss M., Dayton P. G. The effect of chloral hydrate on bishydroxycoumarin metabolism; a fatal outcome. JAMA. 1966 Aug 1;197(5):366–368. [PubMed] [Google Scholar]
  7. Garrettson L. K., Perel J. M., Dayton P. G. Methylphenidate interaction with both anticonvulsants and ethyl biscoumacetate. JAMA. 1969 Mar 17;207(11):2053–2056. [PubMed] [Google Scholar]
  8. Hansen J. M., Kristensen M., Skovsted L., Christensen L. K. Dicoumarol-induced diphenylhydantoin intoxication. Lancet. 1966 Jul 30;2(7457):265–266. doi: 10.1016/s0140-6736(66)92547-5. [DOI] [PubMed] [Google Scholar]
  9. Hoogland D. R., Miya T. S., Bousquet W. F. Metabolism and tolerance studies with chlordiazepoxide-2-l4C in the rat. Toxicol Appl Pharmacol. 1966 Jul;9(1):116–123. doi: 10.1016/0041-008x(66)90036-6. [DOI] [PubMed] [Google Scholar]
  10. Koch-Weser J. Potentiation by glucagon of the hypoprothrombinemic action of warfarin. Ann Intern Med. 1970 Mar;72(3):331–335. doi: 10.7326/0003-4819-72-3-331. [DOI] [PubMed] [Google Scholar]
  11. Koch-Weser J. Quinidine-induced hypoprothrombinemic hemorrhage in patients on chronic warfarin therapy. Ann Intern Med. 1968 Mar;68(3):511–517. doi: 10.7326/0003-4819-68-3-511. [DOI] [PubMed] [Google Scholar]
  12. Kristensen M., Hansen J. M. Accumulation of chlorpropamide caused by dicoumarol. Acta Med Scand. 1968 Jan-Feb;183(1-2):83–86. doi: 10.1111/j.0954-6820.1968.tb10444.x. [DOI] [PubMed] [Google Scholar]
  13. Kristensen M., Hansen J. M. Potentiation of the tolbutamide effect by dicoumarol. Diabetes. 1967 Apr;16(4):211–214. doi: 10.2337/diab.16.4.211. [DOI] [PubMed] [Google Scholar]
  14. Prescott L. F. Pharmacokinetic drug interactions. Lancet. 1969 Dec 6;2(7632):1239–1243. doi: 10.1016/s0140-6736(69)90766-1. [DOI] [PubMed] [Google Scholar]
  15. Pyörälä K., Nikkilä E. A., Vuopio P., Myllylä G. Coumarin anticogulant requirement in relation to serum cholesterol and triglyceride level. Acta Med Scand. 1968 May;183(5):437–443. doi: 10.1111/j.0954-6820.1968.tb10504.x. [DOI] [PubMed] [Google Scholar]
  16. ROGERS L. A., ALCANTARA G. A., FOUTS J. R. P-AMINOSALICYLIC ACID INDUCED PROLONGATION OF HEXOBARBITAL SLEEPING TIME. J Pharmacol Exp Ther. 1963 Nov;142:242–247. [PubMed] [Google Scholar]
  17. Rothstein E. Warfarin effect enhanced by disulfiram. JAMA. 1968 Nov 11;206(7):1574–1575. doi: 10.1001/jama.1968.03150070112032. [DOI] [PubMed] [Google Scholar]
  18. Rubin E., Lieber C. S. Hepatic microsomal enzymes in man and rat: induction and inhibition by ethanol. Science. 1968 Nov 8;162(3854):690–691. doi: 10.1126/science.162.3854.690. [DOI] [PubMed] [Google Scholar]
  19. Schrogie J. J., Solomon H. M. The anticoagulant response to bishydroxycoumarin. II. The effect of D-thyroxine, clofibrate, and norethandrolone. Clin Pharmacol Ther. 1967 Jan-Feb;8(1):70–77. doi: 10.1002/cpt196781part170. [DOI] [PubMed] [Google Scholar]
  20. Sellers E. M., Koch-Weser J. Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids. Clin Pharmacol Ther. 1970 Jul-Aug;11(4):524–529. doi: 10.1002/cpt1970114524. [DOI] [PubMed] [Google Scholar]
  21. Sellers E. M., Koch-Weser J. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate. N Engl J Med. 1970 Oct 15;283(16):827–831. doi: 10.1056/NEJM197010152831601. [DOI] [PubMed] [Google Scholar]
  22. Solomon H. M., Schrogie J. J. The effect of phenyramidol on the metabolism of bishydroxycoumarin. J Pharmacol Exp Ther. 1966 Dec;154(3):660–666. [PubMed] [Google Scholar]
  23. Solomon H. M., Schrogie J. J. The effect of various drugs on the binding of warfarin-14C to human albumin. Biochem Pharmacol. 1967 Jul 7;16(7):1219–1226. doi: 10.1016/0006-2952(67)90153-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES